SBIR/STTR Research Award
SUPERACTIVE B-GALACTOSIDASE FOR ENZYME IMMUNOASSAY
Award amount
$50,000Program and phase
SBIR · Phase IAward year
1989Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- BOSTON BIOTECHNOLOGY CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
IN DIAGNOSTIC ENZYME IMMUNOASSAYS (EIA'S), ENZYMES ARE CONJUGATED WITH EITHER ANTIGEN OR ANTIBODY TO AMPLIFY THE PRESENCE OF ANTIGEN-ANTIBODY COMPLEXES. CURRENTLY, BETA-GALACTOSIDASE, HORSERADISH PEROXIDASE, AND ALKALINE PHOSPHATASE ARE THE THREE MOST WIDELY USED ENZYMES IN THESE ENZYMES EACH HAVE THEIR RESPECTIVE ADVANTAGES AND DISADVANTAGES. THE IDEAL ENZYME SHOULD HAVE VERY HIGH CATALYTIC EFFICIENCY AND BE ABLE TO USE LOW CONCENTRATIONS OF CHROMOGENIC OR FLUORESCENT SUBSTRATES THAT YIELD VERY LOW BLANK BACKGROUND. THIS IDEAL ENZYME SHOULD MAKE EIA'S MORE SENSITIVE AND RAPID. THE SHORT-TERM OBJECTIVE OF THIS PROJECT IS TO GENERATE BETA-GALACTOSIDASE WITH HIGH CATALYTIC EFFICENCY. THE SPECIFIC AIMS ARE TO CHARACTERIZE THE POSSIBILITIES AND LIMITATIONS OF A PROMISING TECHNIQUE FOR ISOLATING ENZYMES OF DIFFERENT PROPERTIES, SUCH AS HIGH KCAT OR LOWER KM. IN PRELIMINARY STUDIES, THIS TECHNIQUE PRODUCED BETA-GALACTOSIDASE WITH HIGH KCAT. THE TECHNIQUE TO BE EMPLOYED INVOLVES SELECTIVE PROCEDURES FOLLOWING RANDOM MUTATION IN A CHEMOSTAT ENVIRONMENT. THIS APPROACH HAS THE ADVANTAGE OVER SITE-DIRECTED MUTAGENESIS IN THAT DETAILED STRUCTURAL INFORMATION ON THE ENZYME OF INTEREST IS NOT NECESSARY. MOREOVER, THE EVOLUTIONARY APPROACH PROPOSED MAKES AVAILABLE AN UNLIMITED REPERTOIRE OFMUTATIONS AND THEIR COMBINATIONS, RATHER THAN BEING LIMITED BY PRECONCEIVED NOTIONS AS TO THE OPTIMAL STRUCTURE DESIRED.
Technology keywords
Not reported